908 Devices to Participate in Upcoming Investor Conferences

908 Devices will participate in conferences, 2024 Leerink Partners Healthcare Crossroads Conference & William Blair’s 44th Annual Growth Stock Conference.

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

908 Devices reports its first quarter 2024 financial results, highlighting a 5% revenue increase and strong growth in handheld device sales.

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

908 Devices expands its forensics product offerings with the acquisition of RedWave Technology. This enhances the portfolio with portable FTIR technology.

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

908 Devices will report its first-quarter 2024 financial results on April 30, 2024, before market open.

908 Devices Trace Chemical Identification Technology Adopted by European Agencies

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform

908 Devices to Participate in Upcoming Investor Conferences

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

908 Devices Announces MX908 Integration Capabilities

908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

email

Subscribe to Our Communications